Haemonetics Corporation
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2017 | $159.7M | $83.6M | $76.1M | $9.2M |
| FY2018 | $220.4M | $145.6M | $74.8M | $13.0M |
| FY2019 | $159.3M | $40.3M | $119.0M | $17.2M |
| FY2020 | $158.2M | $109.5M | $48.8M | $20.5M |
| FY2021 | $108.8M | $71.8M | $37.0M | $25.5M |
| FY2022 | $172.3M | $75.8M | $96.5M | $24.4M |
| FY2023 | $273.1M | $81.7M | $191.3M | $25.6M |
| FY2024 | $181.8M | $143.6M | $38.1M | $28.3M |
| FY2025 | $181.7M | $142.4M | $39.3M | $29.6M |
| FY2026 | $293.2M | $260.4M | $32.8M | $33.8M |